Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

StatusWithdrawn
PhasePhase 3

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Why the trial stopped
This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised".

Record History

  1. Enrollment target: 0v4
  2. Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised".v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multinational, randomized, double-blind study comparing the efficacy and safety of two single dose regimens of peramivir administered intramuscularly versus placebo in adults with uncomplicated acute influenza.
Trial Details
NCT Number NCT00486980
Lead Sponsor BioCryst Pharmaceuticals
Conditions
(from sponsor)		 Influenza
Related terms Influenza, Human
Updated on ClinicalTrials.gov